N/A N=35 Basic Science

Study to Characterize Effects of Programming in SCS Patients Undergoing a Temporary Trial

Chronic Pain

Bottom Line

View on ClinicalTrials.gov: NCT02988713 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Apr 2022

Primary outcome: Primary: Patient Comfort — 30 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Programming (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Boston Scientific Corporation
Primary completion: Dec 2020

Outcome Measures

Outcome	Result	p-value
PRIMARY Patient Comfort	30	—

Summary

This is a prospective, multi-center, non-randomized, exploratory, single-arm study characterize the effects of programming spinal cord stimulation (SCS) in patients undergoing a Boston Scientific (BSC) spinal cord stimulation (SCS) temporary trial

Eligibility Criteria

Key Inclusion Criteria

Study candidate is undergoing a spinal cord stimulation (SCS) trial of BSC neurostimulation system, per local directions for use (DFU).
Subject signed a valid, Institutional Review Board (IRB)-approved informed consent form.
Subject is 18 years of age or older when written informed consent is obtained.

Key Exclusion Criteria

Subject meets any contraindication in BSC neurostimulation system local directions for use (DFU).

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02988713). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.